Post-stroke neurorehabilitation - consensus of a neurologist and rehabilitation specialist

Time codes:
  • 00:00:05

    Start of the post-stroke rehabilitation program

  • 00:00:59

    The Burden of Stroke and the Basis of Neuroplasticity

  • 00:02:27

    New data on hemorrhagic stroke

  • 00:04:24

    Stroke Aftermath Issues: Disability and Depression

  • 00:07:03

    Neuroplasticity and restoration of brain functions

  • 00:12:18

    The role of the healthy hemisphere in recovery

  • 00:18:37

    Beginning active rehabilitation after a stroke

  • 00:26:10

    Neglect syndrome and its impact on rehabilitation

  • 00:43:27

    Pharmacological support for rehabilitation

  • 01:12:23

    Preparing the patient for gait training

Fedin Anatoly Ivanovich - Doctor of Medical Sciences, Honorary Professor, Head of the University Clinic of Neurology of the Federal State Autonomous Educational Institution of Higher Education Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of the Russian Federation, Scientific Director of the Rehabilitation Clinic in Khamovniki, Honored Doctor of the Russian Federation.

Vitaly Vladimirovich Kovalchuk - MD, Professor, Honored Doctor of the Russian Federation, Chairman of the Society of Rehabilitation Specialists of St. Petersburg, Head of the Medical Rehabilitation Center, Head of the Department of Rehabilitation of Patients with CNS Disorders of the St. Petersburg State Healthcare Institution "City Hospital No. 38".

Announcement:

In the webinar, experts discuss modern approaches to rehabilitation after a stroke and consider such issues as:

  • Neuroplasticity – how the brain recovers from damage;
  • The role of pharmacotherapy – how Mexidol (ethylmethylhydroxypyridine succinate) improves functional recovery and reduces the effects of ischemia;
  • Neglect syndrome - how to recognize and correct it in time;
  • Multidisciplinary rehabilitation is a combination of drug and non-drug methods (occupational therapy, exercise therapy, psychocorrection).

Key takeaway: Mexidol is one of the most effective neuroprotectors, confirmed by clinical studies, including improvement of motor functions, cognitive recovery and quality of life of patients.

Although the focus is on antidepressants, it is emphasized that drugs with neuroprotective action (such as Mexidol) also affect BDNF (brain-derived neurotrophic factor), improving recovery.

Watch the full recording for details!

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com